Interest in learning of personal genetic risk for cancer: A general population survey

Preventive Medicine

Volumn 25, Issue 5, 1996, Pages 527-536

  Andrykowski, Michael A ^a   Munn, Rita K ^a   Studts, Jamie L ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

cancer; genetics; risk notification; survey

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; COLON CANCER; FAMILIAL CANCER; FEMALE; GENETIC PREDISPOSITION; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; OVARY CANCER; POPULATION RISK; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 0030249722     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.1996.0086     Document Type: Article

References (32)

1. 1. King MC, Rowell S, Love SM. Inherited breast and ovarian cancer: what are the risks? What are the choices? JAMA 1993;269:1975-80.
2. 2. Lerman C, Audrain J, Croyle RT. DNA-testing for heritable breast cancer risks: lessons from traditional genetic counseling. Ann Behav Med 1994;16:327-33.
3. 3. Biesecker BB, Boehnke M, Calzone K, Markel DS, Garber JE, Collins FS, Weber BL. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 1993;269:1970-74.
4. 4. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-9.
5. 5. Shattuck-Eidens D, McClure M, Simard J, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. JAMA 1995;273:535-41.
6. 6. Conneally PM. Huntington disease: genetics and epidemiology. Am J Hum Genet 1984;36:506-26.
7. 7. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993;52:678-701.
8. 8. Wingo PA, Tong T, Bolden S. Cancer statistics 1995. CA Cancer J Clinicians 1995;45:8-30.
9. 9. Croyle RT, Lerman C. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Prev Med 1993;22:284-92.
10. 10. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994;12:843-50.
11. 11. Lerman C, Seay J, Balshem A, Audrain J. Interest in genetic testing among first degree relatives of breast cancer patients. Am J Med Genet 1995;57:385-92.
12. 12. Harris DM, Guten S. Health protective behavior: an exploratory study. J Health Soc Behav 1979;20:17-29.
13. 13. Becker MH, Drachman RH, Kirscht JP. Motivations as predictors of health behavior. Health Serv Rep 1972;87:852-62.
14. 14. Lau RR, Hartman KA, Ware JE Jr. Health as a value: methodological and theoretical considerations. Health Psychol 1986;5:25-43.
15. 15. Maiman LA, Becker MH. The health belief model: origins and correlates in psychological theory. Health Educ Monogr 1974;2:336-53.
16. 16. American Cancer Society. Cancer facts and figures - 1995. Atlanta: Am Cancer Soc, 1995.
17. 17. Stewart AL, Hays RD, Ware JE Jr. The MOS Short-Form General Health Survey: reliability and validity in a patient population. Med Care 1988;26:724-35.
18. 18. Wright JW, editor. The universal almanac. Kansas City (MO): Andrews & McMeel, 1993.
19. 19. Gamble VN. A legacy of distrust: African-Americans and medical research. Am J Prev Med 1993;9:35-8.
20. 20. Lerman C, Audrain J, Croyle RT. DNA-testing for heritable breast cancer risks: lessons from traditional genetic counseling. Ann Behav Med 1994;16:327-33.
21. 21. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being screened annually. J Natl Cancer Inst 1989;81:1879-86.
22. 22. Sattin RW, Rubin GL, Webster IA, et al. Family history and the risk of breast cancer. JAMA 1985;253:1908-13.
23. 23. Scheier MF, Carver CS. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol 1985;4:219-47.
24. 24. Miller SM. Monitoring and blunting: validation of a questionnaire to assess styles of information seeking under threat. J Pers Soc Psychol 1987;52:345-53.
25. 25. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs (NJ): Prentice Hall, 1980.
26. 26. Crauford D, Kerzin-Starrar L, Dodge A, Harris R. Uptake of presymptomatic predictive testing for Huntington's Disease. Lancet 1989;21:603-5.
27. 27. Evers-Kiebooms G, Swerts A, Cassiman JJ, Van Den Berghe H. The motivation of at-risk individuals and their partners in deciding for or against predictive testing for Huntington's disease. Clin Genet 1989;35:29-40.
28. 28. Smurl JF, Weaver DD. Presymptomatic testing for Huntington chorea: guidelines for moral and social accountability. Am J Hum Genet 1987;26:247-57.
29. 29. Eardley A, Elkind AK, Spencer B, Hobbs P, Pendleton LL, Haran D. Attendance for cervical screening - whose problem? Soc Sci Med 1985;20:955-62.
30. 30. Olsen SJ, Frank-Stromberg M. Cancer prevention and early detection in ethnically diverse populations. Semin Oncol Nurs 1993;9:198-209.
31. 31. Rimer BM. Mammography use in the U.S.: trends and the impact of interventions. Ann Behav Med 1994;16:317-26.
32. 32. Stein JA, Fox SA, Murata PJ. The influence of ethnicity, socioeconomic status, and psychological barriers on use of mammography. J Health Soc Behav 1991;32:101-13.